Metabolism of bioactive lipids
The Laboratory focuses on the analysis of lipid mediators (eicosanoids, docosanoids, endocannabinoids) using the UPLC-MS/MS method, in particular to identify the source of production of various mediators and their effect on metabolism and immune cells (i.e. adipocytes vs. macrophages). Currently, the lab is exploring new anti-diabetic lipids, fatty acid esters of hydroxy fatty acids and lipid-related metabolic pathways using stable isotopes and LIMeX platform.
GTTAtlas - interactive metabolomics and lipidomics atlas of mouse tissues during oral glucose tolerance test (OGTT).
MetaboAtlas21 - a comprehensive atlas of the mouse metabolome and lipidome.
LORA - a Lipid Over-Representation Analysis tool.
Projects
Software:
GTTAtlas
MetaboAtlas21
Mapper
Reaction network viewer
LORA
Methodological highlighs from publications using small molecule omics techniques.
More
White adipose tissue (WAT) is a complex endocrine organ and its low-grade inflammation in obesity contributes to the development of metabolic disorders. In 2014, a class of WAT-born lipid mediators - fatty acid esters of hydroxy fatty acids (FAHFA) was discovered. FAHFAs are endogenous lipids with anti-inflammatory and anti-diabetic properties, including the enhancement of glucose tolerance, and insulin and glucagon-like peptide 1 (GLP-1) secretion while reducing inflammatory responses [1-5].
More
Naturally occurring long-chain omega-3 PUFA, namely eicosapentaenoic acid (EPA; 20:5 ω-3), docosapentaenoic acid (DPA; 22:5 ω-3), and docosahexaenoic acid (DHA; 22:6 ω-3) exert multiple biological effects...
More
Our lab participates in OPEN SCIENCE initiative and hosts high school students with their project in metabolomics.
More
We run local instances of several services focused on Metabolomics, Lipidomics, Statistical analysis and Chemometrics. As the hardware resources are limited, these tools are available only within campus LAN.
More
Show more
Achievements
More
Our laboratory has been awarded the grant GA20-00317S New metabolic pathway in the synthesis of anti-diabetic lipokines (2020-2022).
More
Ondrej Kuda has been awarded Lumina Quaeruntur praemium.
More
Publications
Martínez-Ramírez; Felipe - Riečan; Martin - Čajka; Tomáš - Kuda; Ondřej
.
Analysis of fatty acid esters of hydroxy fatty acids in edible mushrooms
.
LWT-Food Science and Technology. 2023; 173(1 Jan)); 114311
.
IF = 6.056
[ASEP]
[
doi
]
Čajka; Tomáš - Hricko; Jiří - Rudl Kulhavá; Lucie - Paučová; Michaela - Nováková; Michaela - Kuda; Ondřej
.
Optimization of Mobile Phase Modifiers for Fast LC-MS-Based Untargeted Metabolomics and Lipidomics
.
International Journal of Molecular Sciences. 2023; 24(3)); 1987
.
IF = 6.208
[ASEP]
[
doi
]
Štěpán; M. - Daďová; K. - Matouš; M. - Krauzová; E. - Sontáková; L. - Koc; M. - Larsen; T. - Kuda; Ondřej - Štich; V. - Rossmeislová; L. - Šiklová; M.
Exercise Training Combined with Calanus Oil Supplementation Improves the Central Cardiodynamic Function in Older Women
.
Nutrients. 2022; 14(1)); 149
.
IF = 6.706
[ASEP]
[
doi
]
Riečan; Martin - Palůchová; Veronika - Lopes; Magno - Brejchová; Kristýna - Kuda; Ondřej
.
Branched and linear fatty acid esters of hydroxy fatty acids (FAHFA) relevant to human health
.
Pharmacology and Therapeutics. 2022; 231(Mar)); 107972
.
IF = 13.4
[ASEP]
[
doi
]
Palůchová; Veronika - Čajka; Tomáš - Durand; T. - Vigor; C. - Dodia; Ch. - Chatterjee; S. - Fisher; A. B. - Kuda; Ondřej
.
The role of peroxiredoxin 6 in biosynthesis of FAHFAs
.
Free Radical Biology and Medicine. Part 2; 193(Nov 20 (2022))
.
IF = 8.101
[ASEP]
[
doi
]
Show more
Show more
Kristyna Magno Ondrej Veronika Marina
Speedvac
Growing cells
QTRAP 5500 / SelexION
Growing cells
Eolid Phase Extraction
